# Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression

> **NCT04448431** · PHASE4 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 605 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Vortioxetine
- **DRUG:** Desvenlafaxine

## Key facts

- **NCT ID:** NCT04448431
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-18
- **Primary completion:** 2022-01-06
- **Final completion:** 2022-02-04
- **Target enrollment:** 605 (ACTUAL)
- **Last updated:** 2022-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04448431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04448431, "Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04448431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*